We also observed that RAS pathway mutations occurred in more than half of ALL patients with high hyperdiploidy (67.8%) with a significant association, particularly between a high hyperdiploidy karyotype and NRAS-PTPN11 mutation. The gene discussed is PTPN11; the disease is acute lymphoblastic leukemia.